Conditions: Leukemia Cutis; Myeloid Sarcoma; Untreated Adult Acute Myeloid Leukemia; Untreated Childhood Myeloid Neoplasm Interventions: Drug: Asparaginase; Drug: Bortezomib; Drug: Cytarabine; Drug: Daunorubicin Hydrochloride; Drug: Etoposide; Other: Laboratory Biomarker Analysis; Drug: Mitoxantrone Hydrochloride; Other: Pharmacological Study; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Drug: Sorafenib Tosylate

Principal Investigator:
Shen, Violet

Research Coordinator:
Kathryn Duvall
(714) 509-8646

Visit clinicaltrials.gov for more information about this trial.



  • Clinical Trial Info
  • IRB Number: 110771
  • Sponsor: COG
  • Protocol Number: AAML1031
  • NCT Number: NCT01371981
  • Research Type: Leukemia/Lymphoma
  • Phase: III
  • Status: Active - Closed to Enrollment